TIVINECTIDE
UNII Q5Z4Q4M8AW

Substance Identification & Data

This profile provides standardized clinical and technical data for Tivinectide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Q5Z4Q4M8AW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2762739-36-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

Q5Z4Q4M8AW

CAS Registry Number

2762739-36-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TIVINECTIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C215293

National Cancer Institute reference terminology for clinical and research data.

INN ID

13475

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tivinectide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TIVINECTIDE

Common Names & Synonyms

L-ALANINAMIDE, 5,5'-((12-(2-(2-(2-(2-CARBOXYETHOXY)ETHOXY)ETHOXY)ETHYL)-3,6,9,15,18,21-HEXAOXA-12-AZATRICOSANE-1,23-DIYL)BIS(1H-1,2,3-TRIAZOLE-1,4-DIYL(1-OXO-3,1-PROPANEDIYL)))BIS(N-ACETYL-S-(3-OXO-3-(TETRAHYDRO-3,5-BIS(3-MERCAPTO-1-OXOPROPYL)-1,3,5-TRIAZIN-1(2H)-YL)PROPYL)-L-CYSTEINYL-4-METHYL-L-LEUCYL-L-PROLYL-L-.ALPHA.-GLUTAMYL-L-LYSYL-L-PROLYL-L-TYROSYL-L-CYSTEINYL-L-PHENYLALANYL-L-ALANYL-L-.ALPHA.-ASPARTYL=L-PROLYL=L-TYROSYL-L-NORLEUCYL-L-CYSTEINYL-, CYCLIC (1->8),(1->15),(1'->8'),(1'->15')-TETRAKIS(THIOETHER), (5->1'')-AMIDE WITH S-(3-OXO-3-(TETRAHYDRO-3,5-BIS(3-MERCAPTO-1-OXOPROPYL)-1,3,5-TRIAZIN-1(2H)-YL)PROPYL)-L-CYSTEINYL-L-PROLYL-3-(1-NAPHTHALENYL)-L-ALANYL-L-.ALPHA.-ASPARTYL-L-CYSTEINYL-L-METHIONYL-N6-(AMINOIMINOMETHYL)-L-LYSYL-L-.ALPHA.-ASPARTYL-L-TRYPTOPHYL-L-SERYL-L-THREONYL-L-PROLYL-(4R)-4-HYDROXY-L-PROLYL-L-TRYPTOPHYL-L-CYSTEINAMIDE CYCLIC (1'''->5'''),(1'''->15''')-BIS(THIOETHER)

N6.5,N6.5'-((12-(2-(2-(2-(3-OXO-3-((S3.1,S3.5,S3.15-((1,3,5-TRIAZINANE-1,3,5-TRIYL)TRIS(3-OXOPROPANE-3,1-DIYL))(L-CYSTEINYL-L-PROLYL-3-(NAPHTHALEN-1-YL)-L-ALANYL-L-.ALPHA.-ASPARTYL-L-CYSTEINYL-L-METHIONYL-N6-CARBAMIMIDOYL-LLYSYL-L-.ALPHA.-ASPARTYL-L-TRYPTOPHYL-L-SERYL-L-THREONYL-L-PROLYL-(4R)-4-HYDROXY-L-PROLYL-L-TRYPTOPHYL-L-CYSTEINAMIDE))-N2.1-YL)PROPOXY)ETHOXY)ETHOXY)ETHYL)-3,6,9,15,18,21-HEXAOXA-12-AZATRICOSANE-1,23-DIYL)BIS(1H-1,2,3-TRIAZOLE-1,4-DIYL(1-OXOPROPANE-3,1-DIYL)))BIS(S3.1,S3.8,S3.15-((1,3,5-TRIAZINANE-1,3,5-TRIYL)TRIS(3-OXOPROPANE-3,1-DIYL))(N-ACETYL-L-CYSTEINYL-4-METHYL-L-LEUCYL-L-PROLYL-L-.ALPHA.-GLUTAMYL-L-LYSYL-L-PROLYL-L-TYROSYL-L-CYSTEINYL-L-PHENYLALANYL-L-ALANYL-L-.ALPHA.-ASPARTYL-L-PROLYL-L-TYROSYL-(2S)-2-AMINOHEXANOYL-L-CYSTEINYL-LALANINAMIDE))

TIVINECTIDE [INN]

External Clinical & Regulatory Resources

Previous UNIIQ5Z31T1CRV

Next UNIIQ5Z7TN7N6H